Brief: Context Therapeutics files for mixed shelf of up to $250 mln
06/11/2024 22:31
Nov 6 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS FILES FOR MIXED SHELF OF UP TO $250
MILLION
- SEC FILING
Source text: ID:n0001628280-24-045776
Further company coverage: CNTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202